Trump vows to cut medicine price to match other nations
US President Donald Trump says he will sign an executive order to cut prescription drug prices to the level paid by other high-income countries, an amount he put at 30 per cent to 80 per cent less.
In a post on his Truth Social platform, Trump said he would sign the executive order on Monday morning, US time, to pursue what is known as "most favoured nation" pricing or international reference pricing.
The US pays the most in the world for many prescription drugs, often nearly triple that of other developed nations.
Trump has said he wants to close that spread, but has not publicly specified how and did not provide details in his post.
"They will rise throughout the World in order to equalise and, for the first time in many years, bring FAIRNESS TO AMERICA!" he said.
"I will be instituting a MOST FAVORED NATION'S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World," Trump added.
Drugmakers have been expecting an order that would focus on the Medicare health insurance program, according to four drug industry lobbyists who said they had been briefed by the White House.
The drugmakers expect the order to apply to a universe of drugs beyond those currently subject to negotiation under former president Joe Biden's Inflation Reduction Act.
Because of that law, Medicare has negotiated prices for 10 drugs, with those prices due to be put in place in 2026. More medicines were set to be negotiated later in 2025.
"Government price setting in any form is bad for American patients," Alex Schriver, a spokesperson for the top US drug company lobbying group, the Pharmaceutical Research and Manufacturers of America, said in a statement when asked about Trump's planned executive order.
This is not the first time Trump has tried to tie drug prices to what other countries pay. During his first term, a court blocked a proposed international reference pricing program.
That proposal five years ago was projected by his administration to save taxpayers more than $US85 billion ($A133 billion) over seven years, cutting into US annual spending of more than $US400 billion ($A624 billion) on drugs.
US President Donald Trump says he will sign an executive order to cut prescription drug prices to the level paid by other high-income countries, an amount he put at 30 per cent to 80 per cent less.
In a post on his Truth Social platform, Trump said he would sign the executive order on Monday morning, US time, to pursue what is known as "most favoured nation" pricing or international reference pricing.
The US pays the most in the world for many prescription drugs, often nearly triple that of other developed nations.
Trump has said he wants to close that spread, but has not publicly specified how and did not provide details in his post.
"They will rise throughout the World in order to equalise and, for the first time in many years, bring FAIRNESS TO AMERICA!" he said.
"I will be instituting a MOST FAVORED NATION'S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World," Trump added.
Drugmakers have been expecting an order that would focus on the Medicare health insurance program, according to four drug industry lobbyists who said they had been briefed by the White House.
The drugmakers expect the order to apply to a universe of drugs beyond those currently subject to negotiation under former president Joe Biden's Inflation Reduction Act.
Because of that law, Medicare has negotiated prices for 10 drugs, with those prices due to be put in place in 2026. More medicines were set to be negotiated later in 2025.
"Government price setting in any form is bad for American patients," Alex Schriver, a spokesperson for the top US drug company lobbying group, the Pharmaceutical Research and Manufacturers of America, said in a statement when asked about Trump's planned executive order.
This is not the first time Trump has tried to tie drug prices to what other countries pay. During his first term, a court blocked a proposed international reference pricing program.
That proposal five years ago was projected by his administration to save taxpayers more than $US85 billion ($A133 billion) over seven years, cutting into US annual spending of more than $US400 billion ($A624 billion) on drugs.
US President Donald Trump says he will sign an executive order to cut prescription drug prices to the level paid by other high-income countries, an amount he put at 30 per cent to 80 per cent less.
In a post on his Truth Social platform, Trump said he would sign the executive order on Monday morning, US time, to pursue what is known as "most favoured nation" pricing or international reference pricing.
The US pays the most in the world for many prescription drugs, often nearly triple that of other developed nations.
Trump has said he wants to close that spread, but has not publicly specified how and did not provide details in his post.
"They will rise throughout the World in order to equalise and, for the first time in many years, bring FAIRNESS TO AMERICA!" he said.
"I will be instituting a MOST FAVORED NATION'S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World," Trump added.
Drugmakers have been expecting an order that would focus on the Medicare health insurance program, according to four drug industry lobbyists who said they had been briefed by the White House.
The drugmakers expect the order to apply to a universe of drugs beyond those currently subject to negotiation under former president Joe Biden's Inflation Reduction Act.
Because of that law, Medicare has negotiated prices for 10 drugs, with those prices due to be put in place in 2026. More medicines were set to be negotiated later in 2025.
"Government price setting in any form is bad for American patients," Alex Schriver, a spokesperson for the top US drug company lobbying group, the Pharmaceutical Research and Manufacturers of America, said in a statement when asked about Trump's planned executive order.
This is not the first time Trump has tried to tie drug prices to what other countries pay. During his first term, a court blocked a proposed international reference pricing program.
That proposal five years ago was projected by his administration to save taxpayers more than $US85 billion ($A133 billion) over seven years, cutting into US annual spending of more than $US400 billion ($A624 billion) on drugs.
US President Donald Trump says he will sign an executive order to cut prescription drug prices to the level paid by other high-income countries, an amount he put at 30 per cent to 80 per cent less.
In a post on his Truth Social platform, Trump said he would sign the executive order on Monday morning, US time, to pursue what is known as "most favoured nation" pricing or international reference pricing.
The US pays the most in the world for many prescription drugs, often nearly triple that of other developed nations.
Trump has said he wants to close that spread, but has not publicly specified how and did not provide details in his post.
"They will rise throughout the World in order to equalise and, for the first time in many years, bring FAIRNESS TO AMERICA!" he said.
"I will be instituting a MOST FAVORED NATION'S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World," Trump added.
Drugmakers have been expecting an order that would focus on the Medicare health insurance program, according to four drug industry lobbyists who said they had been briefed by the White House.
The drugmakers expect the order to apply to a universe of drugs beyond those currently subject to negotiation under former president Joe Biden's Inflation Reduction Act.
Because of that law, Medicare has negotiated prices for 10 drugs, with those prices due to be put in place in 2026. More medicines were set to be negotiated later in 2025.
"Government price setting in any form is bad for American patients," Alex Schriver, a spokesperson for the top US drug company lobbying group, the Pharmaceutical Research and Manufacturers of America, said in a statement when asked about Trump's planned executive order.
This is not the first time Trump has tried to tie drug prices to what other countries pay. During his first term, a court blocked a proposed international reference pricing program.
That proposal five years ago was projected by his administration to save taxpayers more than $US85 billion ($A133 billion) over seven years, cutting into US annual spending of more than $US400 billion ($A624 billion) on drugs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
an hour ago
- Sky News AU
China ‘flexing' its muscles while media is ‘distracted' by LA riots
While the media is distracted by anti-Trump and anti-American riots in Los Angeles, the biggest enemies of the West are 'flexing their muscles', according to Sky News host Andrew Bolt. 'Japan now warns that China has sent two of its aircraft carriers into the Pacific for the first time, including in Japan's economic waters,' Mr Bolt said. 'Practicing for what? You may ask.'
Sky News AU
an hour ago
- Sky News AU
‘Cowardly': PM ‘scared' of formal meeting with Donald Trump
The Australian's Foreign Editor Greg Sheridan has labelled Prime Minister Anthony Albanese 'cowardly' for not seeking a formal meeting with US President Donald Trump in Washington. 'He should have a formal meeting; he is obviously scared of a formal meeting,' Mr Sheridan told Sky News host Peta Credlin. 'You can't just curl up into the fetal position and hope the American president doesn't notice you for three years.'
The Age
an hour ago
- The Age
Trump mulls sending migrants from UK and Ireland to Guantanamo
The Trump administration is preparing to begin the transfer of potentially thousands of foreigners who are in the United States illegally to the American military base in Guantanamo Bay in Cuba, starting as early as this week, US officials familiar with the matter said. The foreign nationals under consideration hail from a range of countries. They include hundreds from friendly European nations, including Britain, Italy, France, Germany, Ireland, Belgium, the Netherlands, Lithuania, Poland, Turkey and Ukraine, but also other parts of the world, including many from Haiti. Officials shared the plans with The Washington Post, including some documents, on the condition of anonymity because the matter is considered highly sensitive. The administration is unlikely to inform the foreigners' home governments about the impending transfers to the infamous military facility, including close US allies such as Britain, Germany and France, the officials said. The preparations include medical screening for 9000 individuals to determine whether they are healthy enough to be sent to Guantanamo, notorious for its history as a prison for suspected terrorists and others captured on battlefields in the aftermath of September 11. Loading It is not clear whether the facilities there can accommodate 9000 new detainees, an influx that would amount to a massive increase from the several hundred migrants moved to and from the base this year. But administration officials say the plan is necessary due to a need to free up capacity at domestic detention facilities, which have become overcrowded amid US President Donald Trump's pledge to implement the biggest deportation of undocumented migrants in American history. A document reviewed by The Post said that 'GTMO' – the government acronym for the base – 'is not at capacity'.
